[1] PubMed ID: | 33937054 |
Disease Name: | Adenocarcinoma of Lung |
Sample: | LUAD specimens and cell lines |
Dysfunction Pattern: | Interaction(miR-185-3p/MECP2) |
Validated Method: | In Vivo Experiment//IHC//Western Blot//CCK8//qRT-PCR//Flow Cytometry//RIP//Luciferase Report Assay//Colony Formation Assay//EdU Staining |
Description: | We found that LINC00518 was highly expressed in LUAD specimens and the high-expression was negatively correlated with the overall survival rates. This finding was also proved in the LUAD cell lines. Through a series of in vitro and in vivo experiments, we proved that LICN00518 promoted the cell growth of LUAD by regulating the cell cycle. Moreover, LICN00518 upregulated the expression of MECP2 by mutagenesis of miR-185-3p. |
Causality: | Yes |
Causal Description: | Through a series of in vitro and in vivo experiments, we proved that LICN00518 promoted the cell growth of LUAD by regulating the cell cycle. |
Clinical-realted Application: | We found that LINC00518 was highly expressed in LUAD specimens and the high-expression was negatively correlated with the overall survival rates. |